Covid-19: Roche obtains “priority review” status for its tocilizumab in the United States
By Le360 (AFP) on 04/04/2022 at 07:58 The Swiss laboratory Roche markets RoActemra, which belongs to the tocilizumab class, which, combined with Remdesivir from Gilead, makes it possible to treat …